去骨瓣减压术治疗创伤性脑损伤:随机对照试验汇总分析
该汇总分析纳入7项随机对照试验、共779例创伤性脑损伤(TBI)患者,比较去骨瓣减压术(DHC)与药物治疗(MT)。结果显示DHC组死亡率、术后颅内压(ICP)和术后血肿发生率显著降低、住院时间更短,但不良结局比例显著高于MT组。
要点
- DHC可显著降低TBI患者死亡率、术后ICP及术后血肿发生率。
- DHC组住院时间显著短于药物治疗组。
- DHC组不良结局比例显著高于药物治疗组,需权衡生存与神经功能结局。
核心结论
- DHC可有效降低TBI患者死亡率、ICP发生率和住院时间,但DHC组存活者中不良结局比例显著高于MT组。
研究设计与样本
- 按PRISMA指南检索英文和中文数据库,纳入报告DHC治疗TBI的随机对照试验(RCT)进行meta分析。
- 共纳入7项RCT、779例TBI患者。
- 结局指标包括死亡率、良好结局、不良结局、术后颅内压(ICP)、血肿不良事件和住院时间。
主要发现
- 与MT组相比,DHC组死亡率显著更低(P < 0.00001)。
- DHC组术后ICP显著更低(P < 0.00001)。
- DHC组术后血肿发生率显著更低(P = 0.01)。
- DHC组住院时间显著更短(P = 0.02)。
- DHC组不良结局比例显著高于MT组(P = 0.0001)。
临床怎么用
- 对TBI患者行DHC决策时,需同时考虑其降低死亡率和ICP的获益与存活者不良结局增加的风险。
- 术后应关注血肿等不良事件及住院时间管理。
局限性
- 作者指出该meta分析存在局限性,但未在摘要中具体说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decompressive hemicraniectomy (DHC) is widely applied for patients with traumatic brain injury (TBI). Although previous studies have indicated that DHC can lead to similar or worse outcomes compared with medical treatment (MT) in patients with TBI, recent trials have suggested the benefit of DHC for neurologic function recovery. Therefore, we performed this meta-analysis to assess the efficacy and functional outcomes of DHC in patients with TBI. METHODS: In accordance with PRISMA guidelines, we searched English and Chinese databases to identify relevant randomized controlled trials (RCTs) reporting DHC for TBI. The outcomes measures included mortality, favorable outcome, unfavorable outcome, postoperative intracranial pressure (ICP), adverse events with hematoma, and hospital stay. RESULTS: Seven RCTs with a total of 779 patients with TBI were included in this meta-analysis. Compared with the MT group, the DHC group demonstrated significantly lower rates of mortality (P < 0.00001), postoperative ICP (P < 0.00001), and postoperative hematoma (P = 0.01), and significantly shorter hospital length of stay (P = 0.02). However, the rate of unfavorable outcomes was higher in the DHC group compared with the MT group (P = 0.0001). CONCLUSIONS: Our results indicate that DHC could be effective in reducing the mortality rate, incidence of ICP, and hospital length of stay in patients with TBI. However, the proportion of patients surviving with unfavorable outcomes was significantly higher in the DHC group compared with the MT group. Despite the limitations of the meta-analysis, our findings target extremely important topic and provide important evidence to facilitate clinical decision making.
引用
- Lu G, Zhu L, Wang X, et al. Decompressive Craniectomy for Patients with Traumatic Brain Injury: A Pooled Analysis of Randomized Controlled Trials. World Neurosurg. 2019. PMID: 31491576. doi:10.1016/j.wneu.2019.08.184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。